van Putten W L, de Vries W, Reinders P, Levering W, van der Linden R, Tanke H J, Bolhuis R L, Gratama J W
Department of Statistics, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Cytometry. 1993;14(1):86-96. doi: 10.1002/cyto.990140115.
Lymphocytes, monocytes, granulocytes, and other blood cells can be distinguished on the basis of their forward (FSC) and sideward (SSC) light scatter properties and their expression of CD45 and CD14. A FSC,SSC gate can be set to include > 95% of the lymphocytes using a "back gating" procedure on the CD45+, CD14- cells. However, nonlymphoid cells such as monocytes have light scattering properties similar to lymphocytes. This problem occurs particularly in patient populations where the light scattering properties of lymphocyte subsets have changed (e.g., due to activation) and are similar to those of the monocytes. Thus, immunophenotyping using antibodies specific for other markers than CD45 and CD14 does not allow a direct assessment of the percentage of all lymphocytes positive for those markers. In order to optimize immunophenotyping we have developed analytic model in which the FSC,SSC dot plot is partitioned into six nonoverlapping light scatter regions. Each light scatter region contains a mixture population of different cell types, i.e., lymphocytes, monocytes, granulocytes, and other cells. The proportions of each cell type are known from the CD45,CD14 expression within each light scatter region. Under the assumption of independence of fluorescence and scatter properties conditional on cell type, the expression of markers other than CD45 or CD14 are derived from the cell type composition and the fluorescence properties on the other markers of each light scatter region. The underlying statistical model is a latent class model, and maximum likelihood estimates are computed using the expectation-maximization (EM) algorithm. The application of the model for immunophenotyping of lymphocytes of healthy individuals and cancer patients receiving immunotherapy is shown.
淋巴细胞、单核细胞、粒细胞和其他血细胞可以根据其前向(FSC)和侧向(SSC)光散射特性以及CD45和CD14的表达来区分。可以使用CD45 +、CD14 - 细胞的“反向门控”程序设置FSC、SSC门,以包括> 95%的淋巴细胞。然而,诸如单核细胞等非淋巴细胞具有与淋巴细胞相似的光散射特性。这个问题在淋巴细胞亚群的光散射特性发生变化(例如由于激活)且与单核细胞相似的患者群体中尤为突出。因此,使用针对CD45和CD14以外其他标志物的特异性抗体进行免疫表型分析,无法直接评估那些标志物阳性的所有淋巴细胞的百分比。为了优化免疫表型分析,我们开发了一种分析模型,其中FSC、SSC点图被划分为六个不重叠的光散射区域。每个光散射区域包含不同细胞类型的混合群体,即淋巴细胞、单核细胞、粒细胞和其他细胞。每种细胞类型的比例可从每个光散射区域内的CD45、CD14表达得知。在细胞类型条件下荧光和散射特性独立的假设下,CD45或CD14以外标志物的表达是从每个光散射区域的细胞类型组成和其他标志物的荧光特性推导出来的。基础统计模型是一个潜在类别模型,最大似然估计使用期望最大化(EM)算法计算。展示了该模型在健康个体和接受免疫治疗的癌症患者淋巴细胞免疫表型分析中的应用。